Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:07:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s software revision changed from v3.7.0 to v3.7.1; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:25:00.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error page. This indicates an access restriction rather than changes to the study data.
    Difference
    19%
    Check dated 2026-09-23T01:25:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This reflects a backend or content-management update to the page without altering the study data itself.
    Difference
    0.1%
    Check dated 2026-09-16T00:12:32.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.5 to v3.6.6, indicating a new release version of the page's template.
    Difference
    0.1%
    Check dated 2026-09-01T19:20:39.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the page's revision history, and the previous revision v3.6.4 is removed; this reflects a minor update to the page's metadata rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-08-11T19:16:54.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.